Related references
Note: Only part of the references are listed.Biomarkers for skin involvement and fibrotic activity in scleroderma
P. Moinzadeh et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease
Roger Hesselstrand et al.
RHEUMATOLOGY (2012)
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
J. Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C
J. Parkes et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Biomarkers in the Management of Scleroderma: An Update
Giuseppina Abignano et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Julie Parkes et al.
GUT (2010)
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy
M. Matucci-Cerinic et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Hyaluronan Orchestrates Transforming Growth Factor-β1-dependent Maintenance of Myofibroblast Phenotype
Jason Webber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
COMP:: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
R. Hesselstrand et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
WU Kim et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Aberrant serum hyaluronan and hyaluronidase levels in scleroderma
BA Neudecker et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Serum markers detect the presence of liver fibrosis: A cohort study
WMC Rosenberg et al.
GASTROENTEROLOGY (2004)
European multicentre study to define disease activity criteria for systemic sclerosis.: II.: Identification of disease activity variables and development of preliminary activity indexes
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Circulating collagen metabolites in systemic sclerosis.: Differences between limited and diffuse form and relationship with pulmonary involvement
A Scheja et al.
RHEUMATOLOGY (2000)
Share Paper
